Moreover, other transcriptional factors, such as Elk1 and Ets1, have been reported to control CIP2A gene expression in cervical cancer, endometrial carcinoma, and triple‐negative breast cancer (Liu et al., 2017; Pallai et al., 2012). The gene discussed is CIP2A; the disease is endometrial carcinoma.